Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bioglan AB
AB
Active
Org 5567572119
Borrgatan 31, 211 24
Malmö
Manufacture of pharmaceutical preparations
· NACE 2120
Est. 2008
113 employees
Watchlist
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Bioglan AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
85M
171M
256M
342M
174M
2020
161M
2021
181M
2022
226M
2023
297M
2024
EBITDA
SEK millions
0M
13M
25M
38M
51M
37M
2020
17M
2021
16M
2022
37M
2023
44M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
173 979
161 332
181 212
225 531
297 317
Staff expenses
—
—
—
—
—
EBITDA
36 700
16 861
16 435
36 970
43 554
Depreciation & amort.
−6 881
−4 790
−5 743
−7 355
−4 732
EBIT
29 819
12 071
10 692
29 615
38 822
Net financials
−958
−130
−789
78
559
Profit before tax
28 861
12 569
10 583
29 693
39 381
Tax
−6 188
−2 544
−2 256
−6 518
−8 226
Net profit
22 673
10 025
8 327
23 175
31 155
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
131 150
139 934
188 846
229 226
284 048
Equity
92 294
102 319
110 647
133 821
164 976
Long-term debt
8 230
1 640
0
0
0
Short-term debt
30 626
35 975
78 199
95 405
119 072
Total debt
38 856
37 615
78 199
95 405
119 072
Financial ratios
5-year trend
EBITDA margin
14.6%
This company
15.8%
Market median
-8% vs market
2020
2024
Equity ratio
58.1%
This company
38.2%
Market median
+52% vs market
2020
2024
Return on equity
18.9%
This company
18.4%
Market median
+3% vs market
2020
2024
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
2020
2024
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
2020
2024
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Bioglan AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
